{"name":"Astellas Pharma China, Inc.","slug":"astellas-pharma-china-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Tacrolimus sustained-release capsule","genericName":"Tacrolimus sustained-release capsule","slug":"tacrolimus-sustained-release-capsule","indication":"Prophylaxis of organ rejection in allogeneic kidney, heart, and liver transplant recipients","status":"marketed"},{"name":"Tacrolimus immediate-release formulation","genericName":"Tacrolimus immediate-release formulation","slug":"tacrolimus-immediate-release-formulation","indication":"Organ transplant rejection prophylaxis (kidney, heart, liver)","status":"marketed"},{"name":"ATF-Fresenius S","genericName":"ATF-Fresenius S","slug":"atf-fresenius-s","indication":"Rheumatoid Arthritis","status":"phase_2"},{"name":"Tacrolimus prolonged-release formulation","genericName":"Tacrolimus prolonged-release formulation","slug":"tacrolimus-prolonged-release-formulation","indication":"Prophylaxis of organ rejection in allogeneic kidney, heart, and liver transplant recipients","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"Mycophenolic acid drugs","genericName":"Mycophenolic acid drugs","slug":"mycophenolic-acid-drugs","indication":"Other","status":"marketed"},{"name":"Perdipine injection","genericName":"Perdipine injection","slug":"perdipine-injection","indication":"Other","status":"marketed"},{"name":"Plaebo","genericName":"Plaebo","slug":"plaebo","indication":"Other","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Cyclophosphamide injections","genericName":"Cyclophosphamide injections","slug":"cyclophosphamide-injections","indication":"Lymphomas (Hodgkin and non-Hodgkin)","status":"phase_3"}]}],"pipeline":[{"name":"Tacrolimus sustained-release capsule","genericName":"Tacrolimus sustained-release capsule","slug":"tacrolimus-sustained-release-capsule","phase":"marketed","mechanism":"Tacrolimus inhibits calcineurin phosphatase, suppressing T-cell activation and proliferation to prevent organ rejection and treat autoimmune conditions.","indications":["Prophylaxis of organ rejection in allogeneic kidney, heart, and liver transplant recipients","Atopic dermatitis (eczema)","Autoimmune conditions requiring immunosuppression"],"catalyst":""},{"name":"Tacrolimus immediate-release formulation","genericName":"Tacrolimus immediate-release formulation","slug":"tacrolimus-immediate-release-formulation","phase":"marketed","mechanism":"Tacrolimus inhibits calcineurin phosphatase, blocking T-cell activation and proliferation to suppress immune responses.","indications":["Organ transplant rejection prophylaxis (kidney, heart, liver)","Atopic dermatitis","Autoimmune conditions (off-label use in various settings)"],"catalyst":""},{"name":"ATF-Fresenius S","genericName":"ATF-Fresenius S","slug":"atf-fresenius-s","phase":"phase_2","mechanism":"ATF-Fresenius S is a drug that works by modulating the immune system.","indications":["Rheumatoid Arthritis"],"catalyst":""},{"name":"Cyclophosphamide injections","genericName":"Cyclophosphamide injections","slug":"cyclophosphamide-injections","phase":"phase_3","mechanism":"Cyclophosphamide is an alkylating agent that cross-links DNA strands, preventing cell division and triggering apoptosis in rapidly dividing cells.","indications":["Lymphomas (Hodgkin and non-Hodgkin)","Breast cancer","Ovarian cancer","Leukemias","Multiple myeloma"],"catalyst":""},{"name":"Mycophenolic acid drugs","genericName":"Mycophenolic acid drugs","slug":"mycophenolic-acid-drugs","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Perdipine injection","genericName":"Perdipine injection","slug":"perdipine-injection","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Plaebo","genericName":"Plaebo","slug":"plaebo","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tacrolimus prolonged-release formulation","genericName":"Tacrolimus prolonged-release formulation","slug":"tacrolimus-prolonged-release-formulation","phase":"marketed","mechanism":"Tacrolimus is a calcineurin inhibitor that suppresses T-cell activation by blocking the phosphatase calcineurin, thereby preventing immune rejection.","indications":["Prophylaxis of organ rejection in allogeneic kidney, heart, and liver transplant recipients","Autoimmune diseases including atopic dermatitis and other inflammatory conditions"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNcGx2MnlsR0VPdlZJZWJKQjMzUXY3SEx1dmtHcVpmWVV0UWpLc3pGRzNlMExDOUwtMGhnbDVzVHBPQlp2VExEU1lUazQ3VVZXcmx3a1lMWVFfNHlrZU8zYUI4QnZJaUM1MTFqS2lpQjhWSkthZjMtanhFYy1mQWtNVU1JYXlJY1l3R2xkME92ZTlETTFNQWlYRndSMUMzV3VKMHlCVVFVTHNUVEU3VGZEcVRhazd0Yzg?oc=5","date":"2026-02-27","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up - Fierce Pharma","headline":"Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPVjJYanpwa2Nka1hfaGxkLVk0NGN4X0FTVlJkZ1duUDJNR3h3WXBia2tuVjdfN29mOTFfOGc4NE5kdW9HYWQwYkxhdTZoVUNHWEFheFRVZmlnTXhieUlYdUw5a25RUWgxaXk4WFg2cWpHbkh4eTRNem9jQXh0RW0waXFQb3hHYktJN2c?oc=5","date":"2025-07-29","type":"pipeline","source":"The Japan Times","summary":"Astellas employee makes no appeal against conviction in China - The Japan Times","headline":"Astellas employee makes no appeal against conviction in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPTi1SeGhVMkpaQVcxMU5RUWZRT0RsOXVlQjliSFRrLUZOZVdpV2NUU0lTd3ZmUERBV2tmOHRMNFJZTUREVEpReXp6ZGx5dkVDSUM0YzVTSC1uUmFkanBteHdlV1Q3aHFHMXpNZ1BwLU4xamwwd2F2ckRZX1YzeHAtcWxhQUVIVVRVWXdlQndYajQ?oc=5","date":"2025-07-24","type":"pipeline","source":"JAPAN Forward","summary":"Enact Anti-Espionage Laws to Rescue Japanese Jailed in China - JAPAN Forward","headline":"Enact Anti-Espionage Laws to Rescue Japanese Jailed in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPWlZDWXVRbFB4M28xNXFuMk82dFpkRllhQVl4S1otQkNSSTVfeFJHcHluWjFsaGFsRGY2VlpQZzZpTWUtaUNydEV1UHFkRHdUWU52eFE3bHpTQ0tIOWNfMElkNVdvRDF4ckV6S011NUxkN0g2YXFyRjBHS09aSUN1X1NCOXdIMUdMWXRyajlGWk9OQklOMWJMUFZiVUxtUmFoaWVvcGJn?oc=5","date":"2025-07-20","type":"pipeline","source":"The Japan Times","summary":"Astellas employee won't appeal spying conviction in China - The Japan Times","headline":"Astellas employee won't appeal spying conviction in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE1LcEdtWVZqcWtnWk5zejQxc1JNZGNCWnNvRDN2WF9NOXV1NzVtWUxLYUtrZFdTdk1nQTVlQV9uOEtpVXBTMHV5bU05eENXZHd2U1I0Vk5qVDdjc01RUlNpU01vek1XajlkeXNZTEQycTlCNVk?oc=5","date":"2025-07-17","type":"pipeline","source":"毎日新聞","summary":"Editorial: China's murky sentencing of Japanese man on spy charge stifles business activity - 毎日新聞","headline":"Editorial: China's murky sentencing of Japanese man on spy charge stifles business activity - 毎日新聞","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOOEdLd3pzRElwdHhtVl84V2ZzN251OF9jbWlYbFlaN05BNndtQkpZREY0cmZfVmRaNmVkV1lKNERhaXhvRFRTRllKZmR1MTRaWUM2OV9Wcm00cVdrM1FES1JPdWZOWVlGM0lzTlhXMnVfb1dsbXZEdXFRaXRucFk4eFdockZHVmRfUmI3TUJPbkhfdWRHNG9FWXRFUnEyVWFmT1HSAacBQVVfeXFMT2hTYmVtUmJ4UExobjEzcTR2SlFMR1RxRlAzWlBwdW9fN3NQLW9PTjlzejFST2dWVnY3Q1R6dkZWbnJnUFVsY1N3aHk5YUtscVl1VVVQa3g2cHNhQ3BjV3lRSlh4bTdPN1BLOEdLUzVtQk9BZGs0LUdacFcwU01ad1ZkSzhGU29kNnlGYnBmemk4N0xtUXkzWW1ucllxWFA2eVlmNkkwRWM?oc=5","date":"2025-07-16","type":"pipeline","source":"aljazeera.com","summary":"China jails Japanese businessman for espionage, embassy says - aljazeera.com","headline":"China jails Japanese businessman for espionage, embassy says","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE02Q1VWbEk3cUx5N3FwTmtGRkRwWGtfZ3RUaUp6ZTBCeFU3UWF4OTJxZTg3YWNRSkpmYnBmV2ctM3ptUzlmejkySjlxZ05TaXZrNGg5QUJB?oc=5","date":"2025-07-16","type":"pipeline","source":"朝日新聞","summary":"Astellas Pharma expat sentenced to 3 years and 6 months in prison - 朝日新聞","headline":"Astellas Pharma expat sentenced to 3 years and 6 months in prison - 朝日新聞","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE1UdEJjeTl2b0dsczBvdlZBamZWRGFtMmstd2k1X3lvWmJ0MWh2N2JkN3FvQndzZWdXdEhuREF6OXJsd01IQndEaGZDVThfaG5DakpRdjNidkFJQQ?oc=5","date":"2025-07-16","type":"pipeline","source":"Japan Wire by Kyodo News","summary":"China court sentences Japanese man to 3.5-yrs in jail for spying - Japan Wire by Kyodo News","headline":"China court sentences Japanese man to 3.5-yrs in jail for spying","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPRnB1WGNDWkpMWEdJcTFmT3hrODV0THdFaUlxRC1zcncyS1lMTlpaZFlaWTVoR05pLUpJNzJyckJoWU5zcTBRQXRRZXk4UW1sWlBDZGxtS2lPWVJyZEZYTFBFVjlfUy16SWc2NllZRWFjdmVBaVM5VFZCZk5oQ3dDaGVDRG83QzNPZUVyaWE4dGZoMldOLUMtdUFhUDNoUHhpakJrVENB?oc=5","date":"2025-07-11","type":"pipeline","source":"The Japan Times","summary":"Chinese court to issue ruling on Japanese businessman - The Japan Times","headline":"Chinese court to issue ruling on Japanese businessman","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxNWW5abFNzdTNqb2xnaW9Jakh0UGdYeXVBSGdlMWVUTWFrSVh4S2JIOXh2akVZR3Fia25MVGQ2RVd6eVpUOW5TM0JvUDB4NGkwRVZFSkhwWUczUTlKN2FCOG54NElRYlpZdWItMElzVVI4QWZnQWNZNG5ISXpMZ3l5cHhLR2hWaEN6T2k1QWFrYkFyRzNFN1Q0QWV1OEdtcjBfVXViMW12b0QxNDBScHI3S3R2UHc1ejJiVlBaMTVraWt4TnRnUTNDZUFBYzN4aFN3emRka3FtMk5MOVVjVWRCUU5PS0k2N3M4dE1Mb29ZRm91dXI3NVBJNlE1N3VicU84V3RfM3hyLWlyRVlBc3BiaTBDVlU1cUVRR1AyeGlyNDVZMjFKWk53S19leTRhVkU?oc=5","date":"2025-05-29","type":"deal","source":"PR Newswire","summary":"Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2 - PR Newswire","headline":"Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNajc5QXJIQi1qR2pkVV9CbWFyc2hjRk1yaHpjN0dfYURwY05JMFNRZGVoRTFxVU5fcTM3UXhCaTJSNU9nRWFtOWtPS1pIOGYwbVRXWGhiUDI4LWVWOUdxSFY5MG1BTlVvYmktWjUtcmtzbmVwNzBELW1feWtLeGlVUnhEREhHUF9XU1J5azFMNFJtblNjbUJ3Z043MXY1NzlSNlVGblh4VEwtTE9vRzdQS09kVDk4bVJ6MFVPbjNXcXNLa01vbEV4M3FKdDQ?oc=5","date":"2024-08-21","type":"pipeline","source":"Reuters","summary":"Japan's Astellas says employee indicted by China's prosecutors - Reuters","headline":"Japan's Astellas says employee indicted by China's prosecutors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQWjk2VDN1b2duaEpJWDFrMlk2Qk12ZHU3emIyUW1IMGJDczhqQ2JYOVF6YjZJVGd0Q2lGS2QzU2JPcFhmUGMyZEpnXzZrYnZXYnJxVnhhUGNYTzdBcW5mWEkzVHFwc2N6dHNwQlBxM3hhN3hNcThXbTdkOTRfZkphUlJRd0hlNF9WN2p0R1U3TnNhSzFUbjFFbDJYOV9jSGZNdU1yZGRjOVFTQzd4cHNudUhHdW5KQzA?oc=5","date":"2023-03-26","type":"pipeline","source":"Reuters","summary":"Japanese man detained in China is Astellas Pharma employee - Reuters","headline":"Japanese man detained in China is Astellas Pharma employee","sentiment":"neutral"}],"patents":[],"drugCount":8,"phaseCounts":{"marketed":5,"phase_2":1,"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}